Monoclonal Anti-RSV-post-F0 specific Antibody, Mouse IgG1 (1A2D9D8) (MALS verified), Unconjugated, Multiple

Catalog Number: ABS-RSV-Y180-1MG
Article Name: Monoclonal Anti-RSV-post-F0 specific Antibody, Mouse IgG1 (1A2D9D8) (MALS verified), Unconjugated, Multiple
Biozol Catalog Number: ABS-RSV-Y180-1MG
Supplier Catalog Number: RSV-Y180-1mg
Alternative Catalog Number: ABS-RSV-Y180-1MG
Manufacturer: AcroBiosystems
Host: Multiple
Category: Antikörper
Species Reactivity: Mouse
Conjugation: Unconjugated
Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. The RSV fusion glycoprotein (RSV F) is the principal target of RSV neutralizing antibodies in human sera. The RSV F is a type I viral fusion protein synthesized as inactive, singlechain polypeptides that assemble into trimers. RSV F fuses the viral and host cell membranes by irreversible protein refolding from the labile prefusion conformation to the stable postfusion conformation. - Antikörper
Tag: Mouse IgG1 | Mouse Kappa
Buffer: PBS, pH7.4
Purity: 0.95
Form: Powder
Target: Postfusion glycoprotein F0/post-F protein (RSV)
Immobilized HRSV (A) Post-fusion glycoprotein F0, His Tag (MALS verified) (Cat. No. RSF-V52H6) at 2 µg/mL (100 µL/well) can bind Monoclonal Anti-RSV-post-F0 specific Antibody, Mouse IgG1 (1A2D9D8) (Cat. No. RSV-Y180) with a linear range of 0.488-62.5 ng/mL. The antibody does not bind HRSV (A) Pre-fusion glycoprotein F0, His Tag (MALS verified) (Cat. No. RSF-V52H7) (QC tested).
Monoclonal Anti-RSV-post-F0 specific Antibody, Mouse IgG1 (1A2D9D8) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 0.95.